. When plated in semisolid cultures containing optimal concentrations of IL-3, GM-CSF, KL, EPO, IL-6, and IL-1 these cells did not form colonies. However, when cultured over irradiated stromal cells, cobblestone areas were observed to form after 3 weeks, and harvested cells were able to initiate long-term cultures. To further demonstrate that these cells were indeed stem like, we also tested their ability to engraft and mature in immunocompromised (SCID) mice. Irradiated (400 cGy) SCID mice were transplanted with 2 × 10 3 candidate stem cells which were then injected with recombinant human growth factors every other day. Two months post-transplant the animals were sacrificed. PCR and FACS analysis of marrow and spleen cell samples revealed the presence of cells expressing human CD45 consistent with engraftment of human stem cells and the establishment of murine-human chimerism. Moreover, MNC isolated from transplanted mice formed unambiguously human BFU-E, CFU-GM and B cell colonies when stimulated with the appropriate growth factors. Accordingly, we have identified a relatively rapid and simple mechanism for isolating primitive human hematopoietic cells with stem cell-like properties. We anticipate that this strategy will be useful for experimental and therapeutic applications that require human stem cells in quantity.
Introduction
As the indications for hematopoietic stem cell transplantation expand, and gene therapy moves closer to reality, the need for ready access to human hematopoietic stem cells (HHSC) increases. A number of effective strategies for accomplishing HHSC isolation have been reported. [1] [2] [3] [4] [5] [6] [7] [8] Most rely on the use of monoclonal antibodies to detect surface antigens which are differentially expressed on early and late hematopoietic progenitor cells. [9] [10] [11] [12] Binding of probe antibodies to their cell surface targets can be detected by flow cytometry or with solid phase immunoabsorbants such as paramagnetic particles which may also be employed for isolation or capture of cells bearing the desired phenotype. [9] [10] [11] [12] Using these methods, primitive hematopoietic cells which are devoid of lineage spe- + may be isolated. Cells in this subpopulation may be further categorized on the basis of their ability to be stained with fluorochromes with affinity for DNA or mitochrondria, in particular Hoechst 33342 6 or rhodamine 123 (Rh123), 2, 4, 6 respectively. The most primitive long-term reconstituting stem cells are found in Rh123 low population of CD34 + cells, 2 consistent with a resting phenotype, though this interpretation is somewhat complicated by the demonstration that Rh123 is sensitive to the effects of the multidrug efflux pump. 13 Implicit in these approaches is the need for multiple selections which are time-, labor-, and reagent-intensive.
A relatively simple, rapid and inexpensive method for isolating HHSC would be highly desirable. Previous studies from our laboratory, 9, 14 and others 3, 7 suggest that the CD34 + , kit + fraction of human marrow mononuclear cells (MNC) is enriched in primitive cells with stem-like properties. 3, 7, 8 We hypothesized that if a metabolically quiescent population of cells bearing this phenotype could be isolated, the majority of these cells would be quite primitive and would manifest many of the functional properties used to define HHSC. Accordingly, we attempted to develop a FACS-based method for simultaneously detecting and isolating human marrow cells that were CD34
low in the hope that such an approach would lead to rapid and efficient stem cell isolation. Evidence for the effectiveness of this strategy in presented in this paper.
Material and methods

Cells
Light-density marrow mononuclear cells (MNC) were obtained from 11 consenting healthy donors.
Cell selection MNC (ෂ3-6 × 10 7 ) were simultaneously labeled with phycoerythrin conjugated anti-CD34 monoclonal antibody (MoAb) (anti-HPCA-2PE; Becton Dickinson, Mountain View, CA, USA), an anti-human kit receptor MoAb (kind gift of Dr V Broudy, University of Washington) detected with a Cy5-labeled conjugate, and Rh123 at concentrations we have determined to be non-toxic to hematopoietic cells (1 g/ml). A FACSStar PLUS (Becton-Dickinson, San Jose, CA, USA) was employed for these studies. A 488 nm blue argon laser was the primary cell interrogator, while a 633 nm red helion-neon laser was employed secondarily. A 530 DS 30 filter was utilized for rhodamine (FL-1), while a 575 DS 26 filter was employed for phycoerythrin charcoal-treated BSA (Sigma), 270 g/ml iron saturated transferrin (Sigma), insulin (20 g/ml), 5.6 g/ml cholesterol (Sigma), and 2 mmol/l l-glutamine at 37°C. This period of time was necessary for cells to shed the anti-CD, anti-kit antibodies used for isolation, and to exclude Rh123 from the cells. Thereafter, cells were deposited on cytospin slides, fixed, and then subjected to indirect immunofluorescence for detection of CD33, CD38, CD20 and GPA-A. In brief, cells were probed with anti-CD33, anti-CD38, and anti-CD20 (Becton Dickinson) and anti- 3 cells were cultured in 3.5-cm plastic petri dishes (37°C, 95% air, 5% CO 2 humidified atmosphere) in 1 ml aliquots of Iscove's modified Dulbecco's medium (IMDM) (Gibco BRL, Grand Island, NY, USA) supplemented with 1% delipidated, deionized, charcoal adsorbed bovine serum albumin (BSA) (Sigma), 270 g/ml iron-saturated transferrin (Sigma), 5.6 g/ml cholesterol (Sigma), 2 mmol/l l-glutamine, and 0.8% (w/v) methylcellulose (Methocel MC; Fluka, Switzerland). Recombinant human growth factors, Epo (5 U/ml), IL-3 (20 U/ml), GM-CSF (5 ng/ml), KL (100 ng/ml), IL-6 (40 U/ml), and IL-1 (100 pg/ml) were also added to the cul- tures. Colonies were typed and counted after 14 days using an inverted microscope and standard morphological criteria as we have previously described. [14] [15] [16] Hematopoietic progenitors present in transplanted mice were enumerated using similar techniques. MNC were isolated by FACS from the humeri of control mice, and mice transplanted with human cells. The isolated cells were assayed for human CFU using serum-free methylcellulose cultures as described above. BFU-E were asssayed after addition of Epo (5 U/ml) and KL (100 ng/ml); CFU-GM after addition of IL-3 (20 U/ml) and KL (100 ng/ml), and B lymphocyte colonies after addition of KL (100 ng/ml) and IL-7 (5 ng/ml). Recombinant human growth factors were used in all experiments. Colonies were counted with an inverted microscope on day 14. 
Figure 7
Detection of the murine-human chimerism 4 weeks after transplantation of 2 × 10 3 CD34
low cells into irradiated SCID mouse. Marrow cells and spleen cells from nontransplanted (lanes 1, 2) and transplanted (lanes 3, 4 and 5) were isolated and DNA extracted. Extracted DNA was subjected to PCR using human specific primers for insulin receptor. Two weeks after initial seeding, KL (100 ng/ml), IL-1 (100 pg/ml) and IL-3 (20 U/ml) were added to each well. CAFC were scored after 4 weeks using an inverted microscope. Each assay was carried out in quadruplicate.
Assay for long-term culture-initiating cells (LTC-IC)
bright cells were plated over irradiated (1000 cGy) human stromal cells essentially as described above. One half of the medium was exchanged every 7 days at which time cells in suspension after gentle agitation of the cultures were assayed for CFU-GM, the progeny of LTC-IC present in the culture.
SCID mouse transplantation
Pathogen-free, 6-week-old SCID mice (Taconic Laboratories, Germantown, NY, USA) were exposed to 400 cGy from a gamma irradiation source 24 h prior to transplantation. In the initial experiments, 2 × 10 3 CD34 + , kit + , Rh123 low cells were transplanted into the animals via tail vein injection. The mice were injected subcutaneously every second day with a cytokine cocktail composed of KL (250 ng), IL-3 (60 U) and Epo (12 U). Control mice were injected with saline instead of cells. Four weeks after injection of the cells the mice were sacrificed. The presence of human cells in the murine hosts was evaluated using two different methods. First, PCR was employed to detect human DNA in spleen, liver and brain extracts. Second, FACS analysis of marrow cells was carried out with FITC-labeled anti-human CD45 MoAb (Sigma).
These experiments were subsequently repeated a second time with the same numbers of animals in the transplant, and saline injection groups. Two of the transplanted animals and one of the controls died within 48 h of being injected, presumably of infection. Of the surviving animals, one transplanted with Rh123 low cells and one saline control were sacrificed 9 weeks after transplantation. Human-murine chimerism was evaluated by PCR and FACS as described above. In addition, marrow cells were evaluated for the presence of human hematopoietic colony-forming units as described below.
Cloning assay, human CFU MNC isolated from the mouse transplanted with CD34 + , kit + , Rh123 low cells and from saline-treated mice were plated in serum-free methylcellulose cultures containing recombinant human growth factors appropriate to the CFU lineage being assayed. 10 6 murine MNC were cloned in 1 ml of medium containing 0.8% methylcellulose (Methocel MC; Fluka) in Iscove DMEM supplemented with 1% delipidated, deionized, and charcoal-treated BSA (Sigma), 270 g/ml iron saturated transferrin (Sigma), insulin (20 g/ml), 5.6 g/ml cholesterol (Sigma), and 2 mmol/l l-glutamine in 3.5 cm plastic petri dishes and incubated (37°C, 95% humidity, 5% CO 2 ). CFU-GM were stimulated with kit ligand (KL; 20 ng/ml) and interleukin-3 (IL-3; 20 U/ml); BFU-E with KL (20 ng/ml) and erythropoietin (EpO; 5 U/ml), and B cell colonies with KL (20 ng/ml) and interleukin-7 (IL-7; 10 ng/ml). All growth factors were purchased from R&D (Minneapolis, MN, USA). Colonies were scored at day 14 using an inverted microscope. Individual colonies were plucked up with a Pasteur pipette for PCR and FACS studies.
Detection of human-murine chimerism
The presence of human myeloid cells in transplanted mice was detected using a human specific anti-CD45 MoAb (Sigma). Briefly, light density marrow cells were obtained from the femurs of transplanted mice. 5 × 10 5 cells were incubated (30 min at 4°C) with an FITC conjugated-anti CD45 MoAb (1:100), or with a similarly labeled goat anti-mouse isotype control MoAb. Cells were washed twice in ice cold PBS, resuspended in 1% paraformaldehyde, and then analyzed by FACS.
The presence of human B cell progenitors was demonstrated by growing B lymphocyte colonies in methylcellulose cultures containing KL and IL-7. B cell lineage of cells in the Detection of the murine-human chimerism 9 weeks after transplantation of 2 × 10 3 CD34
+ , kit + , Rh123 low cells into irradiated SCID mouse. Marrow cells were isolated from transplanted mice, plated in serum-free methylcellulose cultures, and stimulated with human specific growth factors to grow BFU-E, CFU-GM, and B cell colonies. After 14 days, individual colonies were removed from the cultures and subjected to PCR using human specific primers for insulin receptor. (a) Ethidium bromide stained gel of PCR products amplified from BFU-E, CFU-GM, and CFU-B lymph . Lanes 1-9 represent results from individual colonies. Lanes 10 and 11 show absence of products from amplification of murine DNA, and water respectively. (b) PCR products shown in (a) were hybridized with sequence-specific radiolabeled probe to document the human origin of the DNA.
Table 1
Colonies formed by MNC isolated from chimeric and control mice
Colony type
Chimeric mouse Control mouse
/dish) were cultured serum free with recombinant human growth factors. BFU-E colonies were stimulated with KL and EPO, CFU-GM with KL and IL-3, and CFU-Blymph with KL and IL-7. Colony numbers were counted on day 14 and are reported as mean ± s.d. of quadruplicate cultures.
colonies was confirmed by staining of cells with a PE-conjugated anti-CD20 MoAb (Immunotech, Westbrook, ME, USA).
The presence of human DNA in murine tissue was detected using PCR primers designed to amplify sequence within the first exon of the human insulin receptor (INS-R) gene. 17 The PCR strategy employed was novel in that primers were designed to be non-hybridizable with murine INS-R sequence at their 3Ј end, thereby precluding amplification of murine DNA. The upstream primer was designed to hybridize at nts 162-183 and had the following sequence: 5Ј-GAT ATC CGG AAC AAC CTC ACT-3Ј. The downstream primer was designed to hybridize at nts 549-570 and had the following sequence: 5Ј-CTG GCA GTG ACT ATG AGT CCA A-3. The employed T m for these PCR primers was 65°C. When annealing was carried out at this temperature only human DNA fragments were amplified. PCR products were run on a 2% agarose gel, and then transfered to nitrocellulose filters. The human origin of the amplified products was confirmed by hybridization with 32 P-labeled probe (5Ј-CCT TGA GGT GAA CCA TCT CGA AGA TGA-3Ј) complementary to human INS-R mRNA nts 409-436. 17 The method was found to have a detection sensitivity of ෂ1 human cell in ෂ10 4 murine cells.
Statistical analysis
Arithmetic means and standard deviations were calculated on a MacIntosh computer using Instat 1.14 (GraphPad, San Diego, CA, USA) software. Data were analyzed using the Student's t-test for unpaired samples. Statistical significance was defined as P Ͻ 0.01. Figure  1 ). The incidence of these cells, in 10 separate normal marrows, was found to range from 0.01-0.05% of the light density marrow MNC. When sorted on to glass slides and examined microscopically, a particularly striking feature of these cells was their morphologic homogeneity ( Figure 2A ). The cells in the CD34
Results
Isolation and initial characterization of CD34
, Rh123 low population were uniformly small, with scant cytoplasm, and approximately the size of a quiescent lymphocyte. Morphologically undifferentiated, the cells were also characterized by nuclei with hyperchromatic chromatin and inconspicuous nucleoli. Immunochemical phenotyping revealed that sorted cells were also CD33 (−), CD38 (−), CD20 (−), and glycophorin A (−). In contrast, CD34
+ , kit + , Rh123 bright cells were much more heterogenous in both size and appearance ( Figure 2B ). In addition to have more abundant cytoplasm, they contained larger, sometimes indented nuclei with more open chromatin, and prominent nucleoli. A number of these cells also displayed features of lineage-specific maturation such as the appearance of fine granules in the cytoplasm.
Clonogeneic potential of CD34
+ , kit + , Rh123 low cells
When plated in semisolid cultures containing optimal concentrations of IL-3, GM-CSF, KL, EPO, IL-6, and IL-1 CD34
bright cells formed numerous colonies of several different types including CFU-Mix, BFU-E and CFU-GM colonies (Figure 3) . In distinct contrast, the CD34 + , c-kit-R + , Rh123 low cells formed only rare, though only morphologically normal, colonies. When plated over irradiated human bone marrow stroma however, numerous cobble stone areas (CAFC) began to appear after 3 weeks of culture (Figure 4) . At 4 weeks the number of CAFCs was estimated to be 1/13 CD34
low cells ( Figure 5 ). If the CAFC cultures were allowed to grow for an additional 2 weeks the cobblestone areas continued to enlarge, and in some areas became confluent ( Figure  4C, D) . Cells floating free in the medium of these cultures were plated into semi-solid media. In the presence of the appropriate growth factors they gave rise to CFU-Mix, BFU-E and CFU-GM colonies.
CAFC were also present in the CD34 + , kit + , Rh123 bright cell population but with an estimated frequency of 1/1700. Since we defined Rh123 bright as those cells which occupied the Ͼ50% fluorescence intensity gate, it was also of interest to determine CAFC frequency in the population of cells found between the Ͼ10% (upper boundary of Rh123 low gate) and Ͻ50% intensity Rh123 staining gate. To approach this question, we carried out CAFC assays on CD34 + , kit + cells from which the Rh123 low cells had been removed. The frequency of CAFC in this population was estimated to be 1/1450 suggesting that CAFC were not present in any appreciable frequency in the Rh middle intensity staining cells.
The ability of each of these populations to maintain longterm bone marrow cultures was also evaluated (Figure 6 ).
When plated over irradiated human fibroblast monolayers, CD34
+ , kit + , Rh123 bright cells exhausted their ability to generate CFU-GM after ෂ2 weeks in culture. The ability of CD34 + , kit + , Rh123 low cells to generate CFU-GM was considerably more robust and did not even reach a maximum until ෂ4 weeks of culture.
Ability of CD34
+ , kit + , Rh123 low cells to engraft in vivo The in vitro studies described above suggested that cells bearing the CD34
low phenotype had many stem cell like properties. However, it remained to be determined whether these cells had the ability to engraft and give rise to mature progeny in vivo, a more rigorous test of stem cell behavior. To address this issue, we carried out transplantation experiments employing a SCID mouse model system. Humanmurine chimerism was evaluated by PCR and FACS and both methods demonstrated the presence of human cells within the murine tissues. For example, PCR primers designed to amplify human specific sequence in the insulin receptor gene, also revealed the presence of human cells in marrow and spleen of animals transplanted with the candidate stem cells ( Figure  7 ). Using FACS, CD45
+ human cells were shown to comprise 3, 9 and 11% of murine marrow cells in each of the transplanted mice, respectively. As expected, neither human cells nor human DNA could be demonstrated in mice which received saline injections instead of CD34 , Rh123 dull cells gave rise to commited human progenitor cells in vitro, we carried out CFU assays with human cytokines on the marrow cells isolated from these animals. As expected, marrow from salinetreated control animals formed few if any colonies when stimulated with the human cytokines. Those colonies which did form were primarily small CFU-E which degenerated rapidly. In contrast, cells from the animal transplanted with the candidate human stem cells were able to form BFU-E, CFU-GM and B cell colonies (Table 1 ). To provide proof that these colonies were of human origin, entire discreet colonies were plucked from the methylcellulose and subjected to PCR analysis using primers designed to amplify human, but not murine, DNA. As shown in Figure 9a , DNA was easily PCR amplified from the plucked colonies. The human origin was confirmed by hybridization with a radiolabeled human specific probe for INS-R (Figure 9b ). We were also able to demonstrate that B cell colonies derived from these animals' MNC were of human origin using a human specific anti-CD20 MoAb (data not shown).
Discussion
Strategies for isolating candidate human hematopoietic stem cells are constantly evolving. Initial recognition that primitive progenitor and stem cells displayed the CD34 antigen, 18 was soon followed by increasingly sophisticated and complex schemes to purify these cells. An approach common to many of these strategies was to first deplete cells which expressed lineage specific markers. Cells in the lineage negative subpopulation were then positively selected for those which expressed markers found on primitive blood cells, in particular CD34 and Thy-1. 18, 19 Though clearly successful in terms of greatly enriching putative stem cells, this approach can be cumbersome because both positive and negative selection must be carried out and a large number of antibodies are typically required. Both of these requirements add considerably to the expense of the procedure and the time required to accomplish the task.
In this paper we report a simplified approach to the problem of stem cell enrichment. The method we describe relies on simultaneous triple staining of unselected MNC with a phycoerythrin-tagged monoclonal antibody recognizing CD34, a cyanin-5 labeled MoAb recognizing kit, and the mitochondrial dye Rh123. If one then FACS sorts on cells that are CD34 + , kit + , and Rh123 low , a population of cells is selected that has many of the attributes assigned to human stem cells. They are rare, comprising 0.05-0.01% of marrow MNC, undifferentiated, and have the ability to support LTBMC, and form CAFC. More importantly, as few as 2 × 10 3 of these cells have the ability to engraft in a live animal model, and to give rise to progenitor cells capable of differentiating into erythroid, myeloid and B lymphocyte cells.
A number of papers describing simplified human stem cell isolation strategies have recently appeared in the literature. These reports are distinguishable from earlier studies in that they document that the cells isolated are capable of engrafting in a live animal model. This is clearly a critical leap because it has become increasingly clear that in vitro assays do not measure the presence or activity of true marrow repopulating, ie stem cells. 9, 10, 12 In these reports, stem cell isolation was based on selection of marrow cells which were CD34 + CD38 − , 5, 20 CD34 + kit low , 3 or CD34 + , Thy-1(+), Rh123 low . 2 It is not certain that the cells we isolate are functionally distinct from the cells reported in these various papers. For example, the frequency of CAFC and long-term engraftment capability we report is quite similar to that of Uchida et al 2 who selected CD34 + , Thy-1 + , Rh123 low cells for their studies. Nevertheless, some differences are apparent. It is possible that the population we selected was more highly enriched for stem cells than those isolated on the basis of CD34 + and CD38 − since we were able to demonstrate engraftment with an order of magnitude less cells. 5, 20 Kawashima et al reported that from 1.2-5 × 10 3 CD34 + , kit low cells were able to engraft long-term in a sheep in utero transplant model. These numbers are quite similar to those reported in this paper. In contrast to these workers however, we did not find it necessary to select kit low cells in order to observe longterm engraftment in all lineages. The explanation for this apparent discrepancy may lie in the fact that in our hands, Rh123 low cells are almost equally distributed between CD34 + , kit low and CD34
+
, kit high cells. The procedure we have employed appears to yield results which are comparable to the results which are cited above. At the same time, the methodology we employed was simple since it can be carried out in a single preparative step requiring fewer reagents. It also yields cells of high purity. Nevertheless, it is important to note that the procedure we report is relatively time-consuming since it takes ෂ4 h to process 5 × 10 7 bone marrow cells and isolate ෂ10 4 cells bearing the desired phenotype. Use of a high speed sorter would clearly obviate this potential drawback and add speed to the advantage of simplicity in isolating these cells. Accordingly, cells isolated in this manner should prove very useful for basic biologic studies and potentially for therapeutic purposes.
